Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 8,100 shares at $138.06 ($1.1M) on 2021-04-12, disclosed to the SEC on 2021-04-13.
Open-market sale of $1.1M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.16 | 863 | $118K | 10.5% |
| 2 | $137.16 | 863 | $118K | 10.5% |
| 3 | $138.06 | 1,400 | $193K | 17.2% |
| 4 | $139.38 | 1,824 | $254K | 22.6% |
| 5 | $139.38 | 1,824 | $254K | 22.6% |
| 6 | $140.22 | 413 |
| $58K |
| 5.1% |
| 7 | $140.22 | 413 | $58K | 5.1% |
| 8 | $141.79 | 400 | $57K | 5.0% |
| 9 | $143.09 | 100 | $14K | 1.3% |
| Total | $138.93 avg | 8,100 | $1.1M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |